Galectin-3 expression in follicular tumours: An immunohistochemical study of its use as a marker of follicular carcinoma

Pathology

Volumn 37, Issue 4, 2005, Pages 296-298

  Ito, Yasuhiro ^a   Yoshida, Hiroshi ^a   Tomoda, Chisato ^a   Miya, Akihiro ^a   Kobayashi, Kaoru ^a   Matsuzuka, Fumio ^a   Yasuoka, Hironao ^b   Kakudo, Kennichi ^b   Inohara, Hidenori ^c   Kuma, Kanji ^a   Miyauchi, Akira ^a  

^a KUMA HOSPITAL   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Follicular carcinoma; Galectin 3; Immunohistochemistry; Thyroid

Indexed keywords

GALECTIN 3; TUMOR MARKER;

ARTICLE; BENIGN TUMOR; CANCER CLASSIFICATION; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; FOLLICULAR CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY;

EID: 23944477069     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020500169545     Document Type: Article

References (18)

1. LiVolsi VA, Asa SL. The demise of follicular carcinoma of the thyroid gland. Thyroid 1994; 4: 233-7.
2. th ed, , New York: Lippincott Williams & Wilkins. 2001; 886-98.
3. Barondes SH, Cooper DNW, Gitt MA, et al. Galectins: structure and function of a large family of animal lectins. J Biol Chem 1994; 269: 20807-40.
4. Barondas SH, Castronovo V, Cooper DNW, et al. Galectins: a family of animal beta-galactoside-binding lectins. Cell 1994; 76: 597-8.
5. Raz A, Zhu D, Hogan V, et al. Evidence for the role of 34-kDa galactoside-binding lectin in transformation and metastasis. Int J Cancer 1990; 46: 871-7.
6. Lotan R, Ito H, Yasui W, et al. Expression of a 31-kDa lectoside-binding lectin in normal human gastric mucosa and in primary and metastatic gastric carcinomas. Int J Cancer 1994; 75: 2818-26.
7. Bresalier RS, Yan P-S, Byrd JC, et al. Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system. Cancer 1997; 80: 776-87.
8. Drickamer K, Taylor ME. Biology of animal lectins. Annu Rev Cell Biol 1993; 9: 237-64.
9. Irimura T, Matsushita Y, Sutton RC, et al. Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages. Cancer Res 1991; 51: 387-91.
10. Xu X-C, El-Naggar AK, Lotan R. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Am J Pathol 1995; 147: 815-22.
11. Bartolazzi A, Gasbarri A, Papotti M, et al. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 2001; 357: 1644-50.
12. Orlandi F, Saggiorato E, Pivano G, et al. Galectin-3 is a presurgical marker of human thyroid carcinoma. Cancer Res 1998; 58: 3015-20.
13. Inohara H, Honjo Y, Yoshii T, et al. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer 1999; 85: 2475-84.
14. Gasbarri A, Martegani MP, Del Prete F, et al. Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. J Clin Oncol 1999; 17: 3492-502.
15. Coli A, Bigotti G, Zucchetti F, et al. Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia. Histopathology 2002; 40: 80-7.
16. Cvejic D, Savin S, Paunovic I, et al. Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. Anticancer Res 1998; 18: 2637-42.
17. Fernandez PL, Merino MJ, Gomez M, et al. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. J Pathol 1997; 181: 80-6.
18. Kovacs RB, Foldes J, Winkler G, et al. The investigation of galectin-3 in diseases of the thyroid gland. Eur J Endocrinol 2003; 149: 449-53.